Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H G Sayer

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Journal of Cancer Research and Clinical Oncology|April 6, 2002
Hepatic veno-occlusive disease (VOD) with complete occlusion of liver venules after tandem autologous stem cell transplantation-- successful treatment with high-dose methylprednisolone and defibrotideH G Sayer, U Will, K Schilling, et al.
Haematology and Blood Transfusion|January 1, 1990
Influence of treatment modality, patient/donor characteristics, and disease stage on the risk of relapse after allogeneic marrow transplantation for acute leukemiaD W Beelen, K Quabeck, U Graeven, et al.
Clinical and Experimental Dermatology|May 15, 2009
Exanthema in Legionnaires' disease mimicking a severe cutaneous drug reactionM Ziemer, K Ebert, G Schreiber, et al.
Medizinische Klinik (Munich, Germany : 1983)|July 15, 1997
[High dose chemotherapy of solid tumors]K Höffken, R Kath, H J Fricke, et al.
Journal of Cancer Research and Clinical Oncology|August 6, 1998
Correlation between granulocyte/macrophage-colony-forming units and CD34+ cells in apheresis products from patients treated with different chemotherapy regimens and granulocyte-colony-stimulating factor to mobilize peripheral blood progenitor cellsW Vogel, C Kunert, K Blumenstengel, et al.
Blood|October 1, 1989
Acute toxicity and first clinical results of intensive postinduction therapy using a modified busulfan and cyclophosphamide regimen with autologous bone marrow rescue in first remission of acute myeloid leukemiaD W Beelen, K Quabeck, U Graeven, et al.
Bone Marrow Transplantation|January 6, 2004
Combined standard graft-versus-host disease (GvHD) prophylaxis with mycophenolate mofetil (MMF) in allogeneic peripheral blood stem cell transplantation from unrelated donorsC Kasper, H G Sayer, L O Mügge, et al.
Bone Marrow Transplantation|November 9, 2004
Impact of early NK cell recovery on development of GvHD and CMV reactivation in dose-reduced regimen prior to allogeneic PBSCTS Scholl, L O Mügge, M Charbel Issa, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1991
Initial treatment of acute graft-versus-host disease with a murine monoclonal antibody directed to the human alpha/beta T cell receptorD W Beelen, H Grosse-Wilde, U Ryschka, et al.
Bone Marrow Transplantation|October 1, 1993
Constant intravenous pentoxifylline infusions in allogeneic marrow transplant recipients: results of a dose escalation studyD W Beelen, H G Sayer, M Franke, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Journal of Cancer Research and Clinical Oncology|April 6, 2002
Hepatic veno-occlusive disease (VOD) with complete occlusion of liver venules after tandem autologous stem cell transplantation-- successful treatment with high-dose methylprednisolone and defibrotideH G Sayer, U Will, K Schilling, et al.
Haematology and Blood Transfusion|January 1, 1990
Influence of treatment modality, patient/donor characteristics, and disease stage on the risk of relapse after allogeneic marrow transplantation for acute leukemiaD W Beelen, K Quabeck, U Graeven, et al.
Clinical and Experimental Dermatology|May 15, 2009
Exanthema in Legionnaires' disease mimicking a severe cutaneous drug reactionM Ziemer, K Ebert, G Schreiber, et al.
Medizinische Klinik (Munich, Germany : 1983)|July 15, 1997
[High dose chemotherapy of solid tumors]K Höffken, R Kath, H J Fricke, et al.
Journal of Cancer Research and Clinical Oncology|August 6, 1998
Correlation between granulocyte/macrophage-colony-forming units and CD34+ cells in apheresis products from patients treated with different chemotherapy regimens and granulocyte-colony-stimulating factor to mobilize peripheral blood progenitor cellsW Vogel, C Kunert, K Blumenstengel, et al.
Blood|October 1, 1989
Acute toxicity and first clinical results of intensive postinduction therapy using a modified busulfan and cyclophosphamide regimen with autologous bone marrow rescue in first remission of acute myeloid leukemiaD W Beelen, K Quabeck, U Graeven, et al.
Bone Marrow Transplantation|January 6, 2004
Combined standard graft-versus-host disease (GvHD) prophylaxis with mycophenolate mofetil (MMF) in allogeneic peripheral blood stem cell transplantation from unrelated donorsC Kasper, H G Sayer, L O Mügge, et al.
Bone Marrow Transplantation|November 9, 2004
Impact of early NK cell recovery on development of GvHD and CMV reactivation in dose-reduced regimen prior to allogeneic PBSCTS Scholl, L O Mügge, M Charbel Issa, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1991
Initial treatment of acute graft-versus-host disease with a murine monoclonal antibody directed to the human alpha/beta T cell receptorD W Beelen, H Grosse-Wilde, U Ryschka, et al.
Bone Marrow Transplantation|October 1, 1993
Constant intravenous pentoxifylline infusions in allogeneic marrow transplant recipients: results of a dose escalation studyD W Beelen, H G Sayer, M Franke, et al.
Pageof 5